Guest guest Posted June 4, 2001 Report Share Posted June 4, 2001 Dear Master Fe NAMASTE could you please let me know the protocol for healing NEUROLEPTIC MALIGNANT SYNDROME? The patient is a 71 year old male admitted to the hospital. He was on these drugs from past 40 yrs. LITHIUM,RELEXON,TRIBIUM & ATVIN. These drugs have created a lot of toxins in his blood and urine. He is in a semi unconsious state,heart,pluse normal. please guide me for the ph treatment. WITH DEEP GRATITUDE, WITH GREETINGS OF LOVE AND LIGHT, i remain, chhaya negandhi------------------- Dear Chaya, Greetings. MEDICAL INFORMATION: NEUROLEPTIC MALIGNANT SYNDROME (NMS) " Neuroleptic malignant syndrome or NMS is a drug-induced disorder, characterized by disturbances in mental status, temperature regulation, and autonomic and extrapyramidal functions. It is a rare, but potentially life-threatening disorder associated with the use of antipsychotic medications and other medications with similar pharmacologic properties. Although NMS is rare, its potential for morbidity and mortality, as well as the wide-spread use of antipsychotic drugs, suggests that the absolute number of cases is significant. Because of its infrequent occurrence, individual practitioners may have limited experience in diagnosing and managing NMS cases. Also, systematic and standardized research has been hampered by the difficulties in collecting a sufficient number of cases, resulting in a lack of consensus on a number of issues. NMS was first described in France during early clinical trials of antipsychotics. Despite studies confirming its occurrence, NMS remained obscure and unrecognized until the 1980s. Since that time, numerous clinical reports and reviews have provided valuable information facilitating the development of standardized criteria and treatment strategies. The defining features of NMS may develop dramatically within hours or insidiously over several days. NMS is diagnosed by the development of muscle rigidity and elevated temperature following the administration of antipsychotic medication. Additional features include changes in mental status (obtundation, catatonia), vital signs (tachycardia, unstable blood pressure), and extrapyramidal function (tremors, dysarthria, dysphagia, drooling). Associated laboratory findings include leukocytosis, elevated creatine phosphokinase, and metabolic acidosis. The neuroleptic malignant syndrome (NMS) is a rare, but life-threatening, idiosyncratic reaction to a neuroleptic medication. The syndrome is characterized by fever, muscular rigidity, altered mental status, and autonomic dysfunction. Although potent neuroleptics (e.g., haloperidol, fluphenazine)are more frequently associated with NMS, all antipsychotic agents, typical or atypical, may precipitate the syndrome [eg, prochlorperazine (Compazine), promethazine (Phenergan), clozapine (Clozaril), risperidone (Risperdal). NMS has also been associated with non-neuroleptic agents that block central dopamine pathways [e.g.,metoclopramide (Reglan), amoxapine (Ascendin), lithium]. CAUSES: 1. All classes of neuroleptics (dopamine D 2-receptor antagonists) are associated with NMS, and dopamine receptor blockade is considered the cause of NMS. 2. Experimental blockade of dopamine in the striatum can cause rigidity, tremor, and rhabdomyolysis. 3. Blockade of dopamine in the hypothalamus can cause impaired temperature regulation and hyperthermia. Risk factors for developing NMS include: increased ambient temperature, dehydration, patient agitation or catatonia, rapid initiation or dose escalation of neuroleptic, withdrawal of anti-Parkinson medication, use of high-potency agents and depot intramuscular preparations, history of organic brain syndrome or affective disorder, history of NMS, or the concomitant use of predisposing drugs (e.g., lithium, anticholinergic agents). LAB STUDIES: Complete blood count (CBC), Blood cultures, Liver function tests (LFTs), Blood urea nitrogen (BUN) and creatinine, Calcium and phosphate levels, CPK, Urine myoglobin, Arterial blood gas (ABG), PT, PTT, INR, Serum and urine toxic screening (e.g., salicylates, cocaine, amphetamines) Imaging Studies, A chest x-ray (CXR) if aspiration pneumonia is a concern, A head CT scan to rule out a structural lesion or before a lumbar puncture (LP). There is no universal agreement on the absolute need for a CT scan prior to the LP in patients without clinical evidence of a structural lesion. The decision is left to the individual practitioner. EMERGENCY DEPARTMENT CARE: Successful treatment requires prompt recognition, withdrawal of neuroleptic agent, exclusion of other medical conditions, aggressive supportive care, and administration of certain pharmacotherapies. 1. A careful history should be taken before starting a new neuroleptic medication. 2. NMS may recur when medications are restarted. 3. Monitor a patient carefully while administering neuroleptic medication to prevent excessive agitation and dehydration, since these conditions may predispose a patient to NMS. 4. Physical restraints may be useful. 5. Stop all neuroleptics. 6. Correct volume depletion and hypotension with IV fluids. 7. Methods to reduce the temperature include: cooling blankets, antipyretics, cooled IV fluids, ice packs, evaporative cooling, and various pharmacotherapies to reduce rigidity (see below). 8. When rhabdomyolysis occurs, maintain vigorous hydration and alkalinize the urine to prevent renal failure. 9. Electroconvulsive therapy (ECT) has been used to treat NMS. Anecdotal success reported. 10. It may be useful in treating an underlying psychiatric disease in those patients unable to take neuroleptics. 11. The patient must be monitored closely to rule out underlying infection. 12. The patient’s psychiatric disease must be evaluated and treated during withdrawal of neuroleptic medication. Further Outpatient Care: NMS may be prolonged. If the patient is discharged, close follow-up care should be given to monitor residual symptoms. If neuroleptics are to be reinstituted, they should be administered at relatively low initial doses. Transfer: If NMS is diagnosed in a psychiatric facility, the patient should be transferred to an acute care medical facility where intensive monitoring and treatment is available. Deterrence/Prevention: Take a careful history before starting a new neuroleptic medication. NMS frequently recurs when medications are restarted. Monitor a patient carefully while administering neuroleptic medication to prevent excessive agitation and dehydration, since these conditions may predispose a patient to NMS. Physical restraints may be useful. COMPLICATIONS: Rhabdomyolysis, renal failure, seizures, respiratory failure, aspiration pneumonia, decompensation of psychiatric disease with the withdrawal of neuroleptics. Patient Education: After an episode of NMS, the patient must be told that he/she is at risk for recurrence if rechallenged with a neuroleptic medication. " PRANIC HEALING TREATMENT: 1. General sweeping with LWG several times. 2. Sweep the front and back solar plexus and the liver. Thorough cleansing is important. Energize the front solar plexus with LWG, LWB, then with LWO. Do not appy LWO if patient is suffering from loose bowel movement or intestinal bleeding. Apply more sweeping. Sweep the liver, stomach, small and large intestines. 3. Sweep the front and back heart chakra. Energize the back heart with LWG, LWV, then with slightly with EV. 4. Sweep the left and right lungs. Energize the back heart DIRECTLY through the back of the lungs with LWB, LWG, then with LWO. Wait for 1 to 2 minutes. Energize with LWR. 5. Sweep the entire spine with LWG. 6. Sweep front and back spleen. Energize slightly with WHITE. Apply more sweeping. 7. Sweep the basic and navel chakras. Energize with WHITE. No energizing of basic chakra if patient has fever. 8. Sweep the hand and sole chakras. Energize them with LWV. (Do this step maximum of ONCE a day.) 9. Sweep alternately with LWG & LWV the entire head and the left and right brain. Sweep the crown, forehead, ajna, back head minor, jaw minor, throat, and secondary throat minor chakras with LWG & LWV. Energize the chakras with LWG, then with more of LWV. 10. Repeat treatment 2 to 3 times a week. 11. Stabilize and release. 12. Alternate advanced pranic healing treatment with pranic psychotherapy. At least about 2 times a week. Give emphasis on sealing cracks and holes and disintegrating negative elementals and thought entities. Love and light, masterfe Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.